About Diabetology & Metabolic Syndrome

What is Diabetology & Metabolic Syndrome?

Diabetology & Metabolic Syndrome, the official journal of the Brazilian Diabetes Society (SBD), is an open access, peer reviewed, online journal that aims to further the understanding of all aspects of diabetes and metabolic syndrome.

The journal presents original material on any aspect of laboratory, animal or clinical research about the physiology and pathophysiology of diabetes and metabolic syndrome. Through offering a high-visibility forum for new insights and discussions, the journal aims to help health care providers improve the management of people afflicted by these syndromes by increasing knowledge and stimulating research in the field.

Diabetology & Metabolic Syndrome reports on basic research and clinical studies in the areas of genetics, pathophysiology, immunology, epidemiology, clinical management, therapeutic strategies, education, nutrition and psychosocial research relevant for the study of diabetes and metabolic syndrome.

Content overview

Diabetology & Metabolic Syndrome considers the following types of articles:

Research: reports of data from original research.

Reviews: comprehensive, authoritative, descriptions of any subject within the journal’s scope. These articles are usually written by opinion leaders that have been invited by the Editorial Board.

Commentaries: short, focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue, such as recent research findings. They focus on specific issues and are about 800 words in length.

Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. All case report articles should indicate that informed consent to publish the information was granted from the patients or their guardians.

Short reports: brief reports of data from original research.

Letters to the Editor: these can take three forms: a substantial re-analysis of a previously published article, or a substantial response to such a re-analysis from the authors of the original publication, or an article that may not cover 'standard research' but that may be relevant to readers.

Peer review policy

All submitted manuscripts will be evaluated by the Editors-in-Chief or experts from the Editorial Board and suitable manuscripts then sent for peer review. The reports of at least two reviewers will be considered when deciding on acceptance or rejection of a manuscript; a further reviewer will be invited in cases where these reviewers disagree. Final decisions, however, rest with the Editors-in-Chief, who aim to provide an initial decision within six weeks.

Edited by Daniel Giannella-Neto and Marilia de Brito Gomes, Diabetology & Metabolic Syndrome is supported by an expert Editorial Board.

Publishing in Diabetology & Metabolic Syndrome

All articles are listed in PubMed immediately upon acceptance (after peer review), and are covered by PubMed Central and CAS.

Articles in Diabetology & Metabolic Syndrome should be cited in the same way as articles in a traditional journal. However, because articles in this journal are not printed, they do not have page numbers. Instead, they have a unique article number.

The following citation:

Diabetol Metab Syndr 2004, 2:1

refers to article 1 from volume 2 of the journal.

As an online journal, Diabetology & Metabolic Syndrome does not have issue numbers. Each volume corresponds to a calendar year.

To keep up to date with the latest articles from Diabetology & Metabolic Syndrome, why not register to receive alerts? Registration also enables you to customise your subject areas of interest, store your searches, and submit your manuscripts.

Submission of manuscripts

Manuscripts should be submitted electronically to Diabetology & Metabolic Syndrome using the online submission system. Full details of how to submit a manuscript are given in the instructions for authors.

General journal policies

Diabetology & Metabolic Syndrome is published by BioMed Central, an independent publisher committed to ensuring peer-reviewed biomedical research is open access. That means it is freely and universally accessible online, it is archived in at least one internationally recognised free access repository, and its authors retain copyright, allowing anyone to reproduce or disseminate articles, according to the BioMed Central copyright and licence agreement. Diabetology & Metabolic Syndrome however, has taken this further by making all its content open access.

Diabetology & Metabolic Syndrome's articles are archived in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and also at INIST in France and in e-Depot, the National Library of the Netherlands' digital archive of all electronic publications. The journal is also participating in the British Library's e-journals pilot project, and plans to deposit copies of all articles with the British Library.

Diabetology & Metabolic Syndrome is able to deliver summaries of frequently updated content via Really Simple Syndication (RSS) feeds. These are accessible via the orange "XML" button at the top of the list of recent articles or the list of most accessed articles. For more information about RSS feeds see our publisher's website.

For further information about general policies please see the instructions for authors.